Nanalysis Scientific Corp. (TSXV:NSCI)
Canada · Delayed Price · Currency is CAD 0.1250
0.00 (0.00%)
At close: Jul 31, 2026
Nanalysis Scientific Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 40.2 | 40.13 | 45.5 | 28.47 | 24.82 | 16.04 | |
Revenue Growth | -10.51% | -11.79% | 59.82% | 14.69% | 54.72% | 103.75% |
Cost of Revenue | 5.39 | 5.74 | 9.19 | 9.61 | 11.08 | 5.8 |
Gross Profit | 9.65 | 9.96 | 12.75 | 3.97 | 10.47 | 10.24 |
Selling, General & Admin | 9.19 | 9.71 | 10.27 | 11.37 | 12.94 | 7.69 |
Depreciation & Amortization Expenses | 3.17 | 3.19 | 4.35 | 4.37 | 4.56 | 2.51 |
Research & Development | 0.52 | 0.43 | 0.54 | 0.68 | 1.47 | 0.64 |
Other Operating Expenses | 0.34 | 0.4 | 8.35 | 1.05 | 1.66 | 1.14 |
Total Operating Expenses | 13.22 | 13.73 | 23.52 | 17.46 | 20.63 | 11.98 |
Operating Income | -3.58 | -3.77 | -10.77 | -13.49 | -10.16 | -1.74 |
Interest Expense | -1.39 | -1.37 | -1.35 | -0.28 | -0.08 | 0 |
Other Non-Operating Income (Expense) | -0.66 | -0.51 | -1.52 | -3.02 | -0.16 | -0.04 |
Total Non-Operating Income (Expense) | -2.05 | -1.87 | -2.86 | -3.31 | -0.24 | -0.04 |
Pretax Income | -5.63 | -5.64 | -13.64 | -16.8 | -10.4 | -1.77 |
Provision for Income Taxes | 0.05 | 0.02 | -0.02 | -0.01 | -0.48 | - |
Net Income | -5.63 | -5.66 | -13.61 | -16.78 | -9.92 | -1.77 |
Net Income to Common | -5.63 | -5.66 | -13.61 | -16.78 | -9.92 | -1.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 113 | 115 | 111 | 99 | 92 | 70 |
Shares Outstanding (Diluted) | 113 | 115 | 111 | 99 | 92 | 70 |
Shares Change | -5.37% | 3.68% | 11.56% | 7.25% | 31.35% | 7.77% |
EPS (Basic) | -0.05 | -0.05 | -0.12 | -0.16 | -0.10 | -0.03 |
EPS (Diluted) | -0.05 | -0.05 | -0.12 | -0.16 | -0.10 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 0.38 | 3.17 | 3.21 | -11.92 | -10.67 | -1.79 |
Free Cash Flow Growth | -91.47% | -1.15% | - | - | - | - |
Free Cash Flow Per Share | 0.00 | 0.03 | 0.03 | -0.12 | -0.12 | -0.03 |
Gross Margin | 23.99% | 24.83% | 28.02% | 13.95% | 42.18% | 63.83% |
Operating Margin | -8.89% | -9.38% | -23.68% | -47.38% | -40.93% | -10.82% |
Profit Margin | -14.01% | -14.10% | -29.92% | -58.96% | -39.95% | -11.05% |
FCF Margin | 0.94% | 7.90% | 7.05% | -41.87% | -43.00% | -11.18% |
EBITDA | -0.19 | -0.34 | -6.15 | -8.82 | -5.51 | 0.83 |
EBITDA Margin | -0.46% | -0.84% | -13.51% | -30.99% | -22.20% | 5.18% |
EBIT | -3.58 | -3.77 | -10.77 | -13.49 | -10.16 | -1.74 |
EBIT Margin | -8.89% | -9.38% | -23.68% | -47.38% | -40.93% | -10.82% |
Effective Tax Rate | -0.94% | -0.34% | 0.16% | 0.07% | 4.65% | 0.00% |